StARD13 Activators, as referenced in this table, are compounds that may indirectly enhance the functional activity of StARD13 by modifying the signaling environment or cellular conditions that StARD13 operates within. These activators do not directly bind to or increase the catalytic activity of StARD13 but may facilitate its role by influencing the post-translational modification, localization, or signaling dynamics of the Rho GTPases that StARD13 regulates. For example, lipid-derived molecules such as lysophosphatidic acid or arachidonic acid can modulate the activities of various signaling pathways, potentially enhancing the conditions under which StARD13 exerts its effects on Rho GTPases and associated cellular processes. The complex interplay of these compounds with cellular signaling pathways underscores the nuanced approaches needed to understand and potentially modulate the activity of regulatory proteins such as StARD13.
StARD13 is a member of the START domain-containing family of proteins and is involved in lipid metabolism and intracellular vesicle trafficking. Activators within this class operate through various mechanisms, with one notable mode of action involving direct binding to StARD13, inducing conformational changes that enhance its ability to interact with lipid molecules. These activators can facilitate the transfer of lipids between cellular membranes, a crucial step in lipid homeostasis and intracellular vesicle formation. In addition to their direct interaction with StARD13, some activators may influence post-translational modifications or protein-protein interactions that modulate the protein's function. By enhancing StARD13 activity, these compounds play a pivotal role in cellular processes such as lipid transfer and vesicle trafficking. StARD13 activators can fine-tune the lipid composition of cellular membranes, impacting membrane dynamics and intracellular trafficking pathways. The study of StARD13 activators provides valuable insights into the molecular mechanisms governing lipid metabolism and vesicle dynamics within cells, contributing to our understanding of cellular homeostasis and intracellular transport processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geranylgeranylpyrophosphate triammonium salt | 6699-20-3 | sc-200849 | 200 µg | $122.00 | ||
Geranylgeranyl pyrophosphate is a substrate for protein geranylgeranylation, a post-translational modification essential for the membrane localization and function of certain Rho GTPases, potentially affecting the regulatory role of StARD13. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $478.00 $1977.00 | ||
A substrate for the protein prenylation process, farnesyl pyrophosphate is required for proper localization and function of some members of the Rho family of proteins, which could modulate StARD13 activity in the cell. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
A polyunsaturated fatty acid that can be converted into bioactive lipids capable of modulating various signaling pathways, potentially influencing StARD13 activity by changing Rho GTPase signaling dynamics. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
While previously mentioned in an inhibitory context, LPA as a bioactive lipid also activates certain GTPases and might modulate the GAP function of StARD13 by affecting its signaling pathways positively. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a signaling sphingolipid that can influence cell survival and cytoskeletal organization and may indirectly affect StARD13 activity through sphingosine-1-phosphate receptors. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A DAG analog that activates protein kinase C and can influence many signaling pathways, possibly affecting StARD13's role in the cell. | ||||||
Phosphatidyl-L-serine | 51446-62-9 | sc-507548 | 10 g | $46.00 | ||
Phosphatidylserine is a phospholipid that can affect the localization and activity of kinases and phosphatases, potentially influencing StARD13 activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
A monounsaturated fatty acid that can alter membrane fluidity and signaling pathways, potentially affecting the function of StARD13 in the cell. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
As a precursor for other phospholipids and a signaling lipid itself, phosphatidic acid can play a role in membrane trafficking and signal transduction, potentially modulating StARD13 activity. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $49.00 $92.00 $215.00 | 1 | |
A precursor in the cholesterol synthesis pathway, squalene can affect membrane composition and cellular signaling, potentially influencing StARD13 function. | ||||||